Evidence for a 1980 HTLV-III infection in a currently asymptomatic B hemophiliac in Italy.

Antibodies reactive with human immunodeficiency virus gag-coded antigens (gag reactive only) are a major cause of enzyme-linked immunosorbent assay reactivity in a blood donor population. J Clin Microbiol (1988) 0.96

Identification of four subsets of human CD3-CD16+ natural killer (NK) cells by the expression of clonally distributed functional surface molecules: correlation between subset assignment of NK clones and ability to mediate specific alloantigen recognition. J Exp Med (1990) 3.63

Heterogeneity of tonsillar subepithelial B lymphocytes, the splenic marginal zone equivalents. J Immunol (2000) 3.13

A novel surface antigen expressed by a subset of human CD3- CD16+ natural killer cells. Role in cell activation and regulation of cytolytic function. J Exp Med (1990) 2.93

Expression and prognostic significance of IAP-family genes in human cancers and myeloid leukemias. Clin Cancer Res (2000) 2.86

Risk factors for carriage of respiratory pathogens in the nasopharynx of healthy children. Ascanius Project Collaborative Group. Pediatr Infect Dis J (1999) 2.52

In vitro activity of teichomycin and vancomycin alone and in combination with rifampin. Antimicrob Agents Chemother (1983) 2.51

Randomized phase III trial evaluating the role of erythropoietin in the prevention of chemotherapy-induced anemia. J Clin Oncol (1997) 2.41

Specific lysis of allogeneic cells after activation of CD3- lymphocytes in mixed lymphocyte culture. J Exp Med (1988) 2.14

Heterogeneous vancomycin resistance in methicillin-resistant Staphylococcus aureus strains isolated in a large Italian hospital. J Clin Microbiol (2000) 1.98

Helicobacter pylori gastric infection and sideropenic refractory anemia. J Pediatr Gastroenterol Nutr (1993) 1.89

Characterization of FOX-3, an AmpC-type plasmid-mediated beta-lactamase from an Italian isolate of Klebsiella oxytoca. Antimicrob Agents Chemother (1998) 1.85

Susceptibility of Streptococcus pneumoniae strains isolated in Italy to penicillin and ten other antibiotics. J Antimicrob Chemother (1995) 1.84

European multicentre evaluation of a commercial system for identification of methicillin-resistant Staphylococcus aureus. Eur J Clin Microbiol Infect Dis (1996) 1.79

Central venous catheter-related complications in children with oncological/hematological diseases: an observational study of 418 devices. Ann Oncol (2005) 1.77

Complete nucleotide sequence of a highly divergent human T-cell leukemia (lymphotropic) virus type I (HTLV-I) variant from melanesia: genetic and phylogenetic relationship to HTLV-I strains from other geographical regions. J Virol (1993) 1.71

Phylogenetic associations of human and simian T-cell leukemia/lymphotropic virus type I strains: evidence for interspecies transmission. J Virol (1994) 1.61

Mortality and causes of death in Italian persons with haemophilia, 1990-2007. Haemophilia (2010) 1.59

Factor VIII gene inversions in severe hemophilia A: results of an international consortium study. Blood (1995) 1.59

A randomized trial of adoptive immunotherapy with tumor-infiltrating lymphocytes and interleukin-2 versus standard therapy in the postoperative treatment of resected nonsmall cell lung carcinoma. Cancer (1996) 1.58

Prospective evaluation of amplification-boosted ELISA for heat-denatured p24 antigen for diagnosis and monitoring of pediatric human immunodeficiency virus type 1 infection. J Infect Dis (1999) 1.58

Expression and location of Hsp70/Hsc-binding anti-apoptotic protein BAG-1 and its variants in normal tissues and tumor cell lines. Cancer Res (1998) 1.57

Inhibition of Pseudomonas aeruginosa virulence factors by subinhibitory concentrations of azithromycin and other macrolide antibiotics. J Antimicrob Chemother (1993) 1.54

Myelodysplasia syndrome and acute myeloid leukemia in patients with congenital neutropenia receiving G-CSF therapy. Blood (2000) 1.54

Nationwide survey in Italy of treatment of Streptococcus pyogenes pharyngitis in children: influence of macrolide resistance on clinical and microbiological outcomes. Artemis-Italy Study Group. Clin Infect Dis (1999) 1.54

Antibiotic resistance in Pseudomonas aeruginosa: an Italian survey. J Antimicrob Chemother (1998) 1.51

Cytolytic T lymphocytes displaying natural killer (NK)-like activity: expression of NK-related functional receptors for HLA class I molecules (p58 and CD94) and inhibitory effect on the TCR-mediated target cell lysis or lymphokine production. Int Immunol (1995) 1.51

One in four people may develop symptomatic hip osteoarthritis in his or her lifetime. Osteoarthritis Cartilage (2010) 1.49

CD16 surface molecules regulate the cytolytic function of CD3CD16+ human natural killer cells. Int J Cancer (1989) 1.48

A stereoselective cobalt-containing nitrile hydratase. Biochemistry (1997) 1.46

Antimicrobial susceptibility patterns of contemporary pathogens from uncomplicated urinary tract infections isolated in a multicenter Italian survey: possible impact on guidelines. J Chemother (2005) 1.45

In vitro activity of the new ketolide telithromycin compared with those of macrolides against Streptococcus pyogenes: influences of resistance mechanisms and methodological factors. Antimicrob Agents Chemother (2000) 1.43

Transient disappearance of serum antiphospholipid antibodies during the course of a thrombotic event in two adolescents with antiphospholipid syndrome receiving prednisone. Clin Exp Rheumatol (1994) 1.40

Teicoplanin Chemistry and Microbiology. J Chemother (2000) 1.40

Evaluation of spontaneous contamination of ocular medications. Chemotherapy (2001) 1.39

Molecular epidemiology of penicillin-resistant Streptococcus pneumoniae isolates recovered in Italy from 1993 to 1996. J Clin Microbiol (1998) 1.38

A new strategy for prenatal diagnosis in a sporadic haemophilia B family. Haemophilia (2001) 1.37

von Willebrand factor: biological function and molecular defects. Pediatr Hematol Oncol (1997) 1.37

In vitro activity of imipenem against enterococci and staphylococci and evidence for high rates of synergism with teicoplanin, fosfomycin, and rifampin. Antimicrob Agents Chemother (1986) 1.35

Flavopiridol induces apoptosis of normal lymphoid cells, causes immunosuppression, and has potent antitumor activity In vivo against human leukemia and lymphoma xenografts. Blood (1998) 1.35

Macrolide resistance mechanisms and expression of phenotypes among Streptococcus pneumoniae circulating in Italy. J Antimicrob Chemother (1999) 1.35

In vitro activity of LY146032 alone and in combination with other antibiotics against gram-positive bacteria. Antimicrob Agents Chemother (1988) 1.33

Surface molecules involved in the activation and regulation of T or natural killer lymphocytes in humans. Immunol Rev (1989) 1.33

Extended intrathecal methotrexate may replace cranial irradiation for prevention of CNS relapse in children with intermediate-risk acute lymphoblastic leukemia treated with Berlin-Frankfurt-Münster-based intensive chemotherapy. The Associazione Italiana di Ematologia ed Oncologia Pediatrica. J Clin Oncol (1995) 1.26

Multicentre evaluation of the VITEK 2 Advanced Expert System for interpretive reading of antimicrobial resistance tests. J Antimicrob Chemother (2002) 1.25

Human Brucella canis outbreak linked to infection in dogs. Epidemiol Infect (2009) 1.22

In vitro activity of rifaximin, metronidazole and vancomycin against Clostridium difficile and the rate of selection of spontaneously resistant mutants against representative anaerobic and aerobic bacteria, including ammonia-producing species. Chemotherapy (2000) 1.21

CD3+4-8-WT31-(T cell receptor gamma+) cells and other unusual phenotypes are frequently detected among spontaneously interleukin 2-responsive T lymphocytes present in the joint fluid in juvenile rheumatoid arthritis. A clonal analysis. Eur J Immunol (1987) 1.20

Biophysical properties of N4 coliphage. Biochim Biophys Acta (1966) 1.19

Imbalances of T cell subpopulations in patients with atopic diseases and effect of specific immunotherapy. J Immunol (1979) 1.19

Infection of rabbits with human immunodeficiency virus. Nature (1988) 1.19

A novel and innovative quantitative kinetic software for virological colorimetric assays. J Virol Methods (1998) 1.19

The physical properties of the deoxyribonucleic acid from N4 coliphage. Biochim Biophys Acta (1966) 1.18

Prevalence of HTLV type I infection in Iran: a serological and genetic study. AIDS Res Hum Retroviruses (1996) 1.15

Novel transcribing activities in N4-infected Escherichia coli. Virology (1974) 1.12

Rifampicin-resistant RNA polymerase and NAD transferase activities in coliphage N4 virions. Nature (1976) 1.12

On the enzymatic activation of NADH. J Biol Chem (2000) 1.11

In vivo genetic variability of the human immunodeficiency virus type 2 V3 region. J Virol (1992) 1.11

Antilymphocyte globulin, cyclosporin, and granulocyte colony-stimulating factor in patients with acquired severe aplastic anemia (SAA): a pilot study of the EBMT SAA Working Party. Blood (1995) 1.06

Mechanical complications related to indwelling central venous catheter in pediatric hematology/oncology patients. Pediatr Hematol Oncol (2001) 1.06

Polypeptides in the succinate-coenzyme Q reductase segment of the respiratory chain. Biochemistry (1977) 1.06

Enzyme immunoassay for evaluation of Toxoplasma gondii growth in tissue culture. J Clin Microbiol (1985) 1.05

Expression and location of pro-apoptotic Bcl-2 family protein BAD in normal human tissues and tumor cell lines. Am J Pathol (1998) 1.04

Specific recognition by CD3- NK cells: a limiting dilution analysis of the frequency of alloreactive CD3- lymphocyte precursors. Int J Cancer Suppl (1989) 1.02

Detection of SHV-5 extended-spectrum beta-lactamase in Klebsiella pneumoniae strains isolated in Italy. Eur J Clin Microbiol Infect Dis (1996) 1.01

Clonal analysis of CD4-CD8- human thymocytes expressing a T cell receptor gamma/delta chain. Direct evidence for the de novo expression of CD8 surface antigen and of cytolytic activity against tumor targets. Eur J Immunol (1988) 1.01

An in vitro model for Toxoplasma infection in man. Interaction between CD4+ monoclonal T cells and macrophages results in killing of trophozoites. J Immunol (1988) 1.01

Surface markers of cloned human T cells with helper or suppressor activity on pokeweed mitogen-driven B cell differentiation. Eur J Immunol (1982) 1.01

Effects of changes in pH, medium and inoculum size on the in vitro activity of different quinolone and fluoroquinolone antibiotics against urinary pathogens. Drugs Exp Clin Res (1987) 1.01

Reactivity of ferric Aplysia and sperm whale myoglobins towards imidazole. X-ray and binding study. J Mol Biol (1982) 1.01

Monuril and modification of pathogenicity traits in resistant microorganisms. Eur Urol (1987) 1.01

Resistance patterns of lower respiratory tract pathogens in Europe. Int J Antimicrob Agents (2000) 1.00

HLA class I molecule expression is up-regulated during maturation of dendritic cells, protecting them from natural killer cell-mediated lysis. Immunol Lett (2001) 0.99

A rapid procedure for the purification of bacterial viruses. Virology (1966) 0.99

Synthesis, antiviral (HSV-1) and antimycotic activities of ethyl or methyl 2,4-disubstituted 5-pyrimidinecarboxylates, 2,4-disubstituted 5-pyrimidinecarboxylic acids and 2,4-disubstituted pyrimidines. Farmaco (1993) 0.99

Arrangement of complex II (succinate-ubiguinone reductase) in the mitochondrial inner membrane. Biochemistry (1979) 0.99

Antibiotic resistance of clinical isolates of Enterococcus in Italy. Clin Infect Dis (1992) 0.99

Inhibition of motility of Pseudomonas aeruginosa and Proteus mirabilis by subinhibitory concentrations of azithromycin. Eur J Clin Microbiol Infect Dis (1992) 0.98

Activity of daptomycin on biofilms produced on a plastic support by Staphylococcus spp. Int J Antimicrob Agents (2008) 0.97

Assignment of human natural killer (NK)-like cells to the T cell lineage. Single allospecific T cell clones lyse specific or NK-sensitive target cells via distinct recognition structures. Eur J Immunol (1984) 0.97

Interspecies transmission of macaque simian T-cell leukemia/lymphoma virus type 1 in baboons resulted in an outbreak of malignant lymphoma. J Virol (1996) 0.96

Regional specificity of HTLV-I proviral integration in the human genome. Gene (1994) 0.96

Chronic idiopathic thrombocytopenia treated with immunoglobulin. Arch Dis Child (1983) 0.95

Dvelopment of coliphage N4: ultrastructural studies. J Virol (1974) 0.95

Diamond-Blackfan anaemia in the Italian population. Br J Haematol (1999) 0.94

Expression of CD10 by human T cells that undergo apoptosis both in vitro and in vivo. Blood (1999) 0.94

Phytohaemagglutinin and lymphocytes from acute lymphocytic leukaemia. Lancet (1966) 0.93

Detection of HIV-1 sequences in children using radioactive and colorimetric polymerase chain reactions. J Med Virol (1994) 0.93

Rapid disappearance from the intestinal tract of bacteria resistant to rifaximin. Drugs Exp Clin Res (1986) 0.93

Evolution of antibiotic resistance in gram-positive pathogens. J Chemother (2000) 0.92

Anti-cell antibodies in exposed seronegative individuals with HIV type 1-neutralizing activity. AIDS Res Hum Retroviruses (2000) 0.92

Urinary JCV-DNA testing during natalizumab treatment may increase accuracy of PML risk stratification. J Neuroimmune Pharmacol (2012) 0.91

Seasonal variations in nasopharyngeal carriage of respiratory pathogens in healthy Italian children attending day-care centres or schools. J Med Microbiol (2001) 0.91

Zoster sine herpete causing encephalomyelitis. Ital J Neurol Sci (1987) 0.91

Level of human immunodeficiency virus DNA in peripheral blood mononuclear cells correlates with efficacy of antiretroviral therapy. J Clin Microbiol (1999) 0.91

Epidemiology of major respiratory pathogens. J Chemother (2001) 0.90

Metabolic and genetic risk factors for migraine in children. Cephalalgia (2006) 0.90

Relation between CD4 cell counts and HIV RNA levels at onset of opportunistic infections. J Acquir Immune Defic Syndr (2001) 0.90